← All organizations
Highest phase reached
Phase 3
Acquired by Pacira Pharmaceuticals on Oct 13, 2021
Timeline
2000s
- Jul 1, 2007
Flexion Therapeutics— Founded
2010s
- Oct 6, 2017
triamcinolone— NDA Secondary Org
2020s
- Oct 13, 2021
Pacira Pharmaceuticals— Acquired By
Drugs by trial phase (5 distinct, 20 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (31)
- NCT04826328Study directorPhase 1Mar 15, 2021
- NCT04826328Lead sponsorPhase 1Mar 15, 2021
- NCT04261049CollaboratorPhase 1Mar 31, 2020
- NCT04182672CollaboratorPhase 2Jan 6, 2020
- NCT04119687Study directorPhase 1Dec 31, 2019
- NCT04119687Lead sponsorPhase 1Dec 31, 2019
- NCT04160091Study directorPhase 2Nov 7, 2019
- NCT04160091Lead sponsorPhase 2Nov 7, 2019
- NCT04065074Lead sponsorPhase 2Jul 30, 2019
- NCT04065074Study directorPhase 2Jul 30, 2019
- NCT03793010Study directorPhase 3Dec 12, 2018
- NCT03793010Lead sponsorPhase 3Dec 12, 2018
- NCT03529942Study directorPhase 3Apr 24, 2018
- NCT03529942Lead sponsorPhase 3Apr 24, 2018
- NCT03382262Lead sponsorPhase 2Dec 18, 2017
Details
- Founded
- Burlington, MA, US Jul 1, 2007
- Last known activity
- Mar 15, 2021